SAVA Spreads OEM Arm

The SAVA group constitutes independent and well-established entities in manufacturing, marketing, retail and distribution to cover the entire value-chain in pharmaceuticals. End Quote

(1888PressRelease) August 24, 2012 - The Indian Contract Research and Manufacturing Services (CRAMS) market is hovering on the brink of exponential growth. The current global pharmaceutical outsourcing business is estimated at $67 billion of which the market share of the Indian Contract Research and Manufacturing Services (CRAMS) market is at around $ 3.8billion and is expected to grow at a CAGR of 41.4% with custom manufacturing leading the pack. India has always been the preferred global outsourcing hub.

The SAVA group constitutes independent and well-established entities in manufacturing, marketing, retail and distribution to cover the entire value-chain in pharmaceuticals. This along with strategically prominent marketing nodes the world over, gives SAVA, the edge to be self-sustained in effectively delivering a vast range of products across various geographies.It is the vision of Sava to provide integrated drug development, research and manufacturing services so as to emerge as a single stop shop for all the medical needs of multinational pharmaceutical giants. The mission is to establish a long term research driven knowledge partnership and a leading customer driven scientific innovation franchise under its novel business arm 'Ingenius'. Ingenious paves the way to SAVA's indigenously genius inhabitant scientists get together on a common platform and provide unparalleled generation- next innovations drive to establish Sava's leadership through craftsmanship in drug research and custom manufacturing.

The contract manufacturing market valued at $2.3 billion dominates the Indian CRAMS business capturing 60 percent of the market in India. In this space, SAVA CMO Ingenius business arm offers a comprehensive contract manufacturing services from product development to bulk production including process development and optimization, process scale up and validation, Multi kilo pilot plant production and Bulk production.

SAVA's Generic manufacturing plant located in Surendranagar near Ahmedabad in India, helps SAVA attain its magnanimous capability of "curative power" by producing over 500 products in what stands as one of the widest range of therapeutic categories in India. Biodeal is WHO GMP certified manufacturer of various dosage forms. The plant possesses the highest capacity manufacturing line for liquid dosage forms. The plant is designed to manufacture oral solid dosage forms like tablets, capsules and liquid orals under various therapeutic categories. The plant follows an integrated quality system meeting the customer and regulatory requirements to ensure safety and efficacy of the products. Regulatory accreditations include WHO-GMP, NAFDAC (Nigeria), NDA (Uganda), PPB(Kenya), MOH(Iran), MCAZ(Zimbabwe), MOH (D.R.Congo), Paho (USA), MOH (Yemen).

With technology experience of over 3 decades, Biodeal laboratories are today the leading manufacturer of nasal sprays, tablets, general capsules, syrups, suspension, ointment, cream, gel and dry powder inhalers. The heritage of SAVA stands tall on the nasal spray device and technology. The first nasal spray that was introduced in India originated from a SAVA group company. One of Sava's recent advances in the respiratory category is the Savahaler, an advanced dry powder inhaler with a breath activated DPI and a reusable device. The Savahaler is designed to deliver metered dosages from a capsule. Savahaler has been designed with a focus on convenience of use. SAVA stands proud on its world-class infrastructure and cutting edge technology to achieve all its manufacturing excellence. High Performance Liquid Chromatography, Fourier transforms, Infra-red spectrophotometer, Ultraviolet-visible spectrophotometer and Gas Chromatography are some among the full proof infrastructure support systems deployed by the SAVA in the manufacture of advanced finished formulations.Sava has earned a recognition as a leading third party contract manufacturer for various national and multinational houses such as Abbott, Diachi-Sankyo Ranbaxy, Dr Reddy's labs to name a few.

Our multi locational manufacturing facilities delivering large volumes of pharmaceutical dosage forms cater the growing needs of the market. In general wellness and preventive healthcare , another group company of Sava, SAVESTA herbals, is committed to developing and bringing the most potent line of herbal supplements, bulk extracts and Bio actives that combine the ancient wisdom of Ayurveda with advanced phyto-technology harvestation methods to create optimal health and well-being of the general population. Currently Savesta manufactures these standardized herbal extracts in state of the art ultra modern nutraceutical unit which strictly adheres to GMP and is certified by KOSHER and HALAL. Our ultra modern manufacturing facilities have an installed capacity to manufacture 170 metric tons of herbal extract per annum.

These manufacturing facilities are accredited by WHO GMP, ISO 22000:2005, and ISO 9001:2000.

Animal health care in the recent times has emerged as one of the key focus areas for Sava, where we are engaged in the formulation of the unique competitive product range to meet the unmet needs of animal pet- care market, most particularly ticks and fleas products which is global 40billion dollar market. The modern manufacturing facilities equipped with high end machines like DGS-350 and features like system utility optimization, dedicated air handling units for process rooms and built in automation systems deliver large volume of finished products with unmatched quality.

Further, the Indian contract research market is estimated to be $1.5 billion. Estimates say that about 20 percent of spending in R&D is outsourced to India to cut costs. To leverage on its research strengths and develop global technology partnership platforms, Sava has developed a state- of-the- art Research and development center at Pune. At SAVA, we believe that Research and Development are the DNA and the backbone of the pharmaceutical Industry. Reckoning this as a fundamental, innovation and continuous development, form the hallmark of our R&D center. The fully equipped R&D facility with ultra-modern equipment and a team of highly qualified and experienced scientists provide SAVA an edge, to develop superlative quality products with enviable economy.

The Ingenius research business unit remains focused on innovation and continuous improvement in new drug delivery system [NDDS], development of Novel Biological Entities (NBE's) and other niche products or biomarkers, the development of bioactives, bioequivalent studies of existing formulation, quantitative and qualitative evaluation of proprietary dosage forms, providing innovative and significant therapeutic benefits over the existing therapy. Sava's R&D facility is equipped to engage a wide variety of dosage forms in its research and development agenda with solid oral dosage forms like tablets, capsules, powder, suppositories , semisolid dosage forms like ointment, creams, gel, paste ,Liquid dosage forms like syrups, oral solutions, lotions, oral suspensions ,Injectable dosage forms like solutions, lyophilized products, suspensions, powder for reconstitutions, liposomal injections , Ophthalmic dosage forms like eye drops, suspensions, emulsions ,Miscellaneous dosage forms like nasal drug delivery, Aerosols, dry powder inhalers, shampoo along with Veterinary formulations such as Spot-on, tablets, pastes etc.

Reliable and reproducible analytical methods are essential to both the pharmaceutical development process and the evaluation of drug product to meet the standard of potency, purity and stability. The Analytical team at the Sava Ingenius Centre is integrated with pre formulation, product development and quality assurance teams to ensure effective and accelerated product development. Sava stands proud on its experience in developing methods for highly complex and unstable drug products that complements the formulation capabilities.

At Sava Ingenius OEM business arm, both research and manufacturing is a science applied through simple thought or an idea and made robust with technology and system driven process application. Our logical, data-driven approach to formulation development provides with more efficient, straightforward process for manufacturing the compound and gives the compound the best chance at success. The focus on analytical excellence leads to the development of methods that are robust and easily transferable. Our entire operations are carried out through validation processes and strong internal controls meticulously monitoring quality at every level, the result is a high quality innovative product with equally satiable value proposition to market. After all, Sava is philosophy of good health and a good life, both of which is accomplished by Ingenious, its OEM business arm harnessing knowledge as its edge, sustainability in its growth and trust and responsiveness as the true competitive advantage ! Visit - www.savaglobal.com Today !!!

About Us:
Esteemed in 2003, we are committed to make life "SAVA" with our range of healthcare products and services that are benchmark of 'Superlative Quality, Enviable Economy'. Built on the sturdy pillars of financial solidarity, stability, reliability, operational expertise, infrastructure, technology and revolutionary business strategy and execution.The Group is amongst one of the fastest emerging pharmaceutical organizations of repute from India. The SAVA Group has attained an iconic stature in pharmaceutical arena making the lives of millions of people feel good.

Contact Us : SAVA MEDICA LIMITED
SAVA House, Off New Airport Road,
Viman Nagar, Pune - 411014 INDIA
Tel.: +91 20 3051 6100
Fax.: +91 20 3051 6161
E-mail: sales ( @ ) savaglobal dot com

###

space

Other Related Press Releases

Infosys Commits to End Child Diarrheal Deaths in India by Infosys Limited
SAVA Spreads OEM Arm by Sava Global
Sketch In Blue Answers What Is A Storyboard by Joedolanpr